October 24, 2019
Velan, Progenics about Lantheus transaction
Velan Capital has issued a statement in which said Progenics has again resorted to false information and misleading Innuendo in seemingly desperate attempt to avoid accountability and deprive stockholders of chance to realize company’s full value.